Skip to main content
Signal8

GLOBUS MEDICAL INC (GMED)

Globus Medical, Inc. is a global medical technology company dedicated to inventing, developing, and marketing a diverse range of healthcare solutions. Their primary focus is on addressing musculoskeletal disorders for patients worldwide. Their extensive portfolio includes a variety of spinal products. These encompass traditional fusion implants like pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devices, all designed to treat conditions such as degenerative diseases, deformities, tumors, and trauma. Furthermore, they offer advanced motion preservation technologies, including dynamic stabilization, total disc replacement, and interspinous distraction devices. The company also provides interventional pain management options for vertebral compression fractures, alongside a selection of regenerative biologic products such as allografts and synthetic alternatives. Beyond spinal care, Globus Medical manufactures solutions for orthopedic trauma, featuring products like fracture plates, compression screws, intramedullary nails, and external fixation systems. They also specialize in hip and knee joint reconstruction, offering modular hip stems, acetabular cups, and various knee arthroplasty implants, including posterior stabilizing and cruciate retaining designs. Additionally, the company engages in the distribution of human cell, tissue, and other cellular and tissue-based products. Established in 2003, Globus Medical, Inc. maintains its corporate headquarters in Audubon, Pennsylvania.

Sector: Surgical & Medical Instruments & Apparatus

Industry: Medical - Devices

Globus Medical, Inc. logo

Globus Medical, Inc.

NYSE:GMEDHealthcare
-0.31%$81.41
AH Close$81.41+0.00%vs close
Mkt Cap$10.93B
Float131.09M
O/S134.26M
Inst Own88.4%
SI6.4%
Dilution
Globus Medical, Inc. logoNYSE:GMED$81.41-0.31%
FormDescription
4
Statement of Changes in Beneficial Ownership
144
Notice of Proposed Sale of Securities
4
Statement of Changes in Beneficial Ownership
144
Notice of Proposed Sale of Securities
10-Q
8-K
4
Statement of Changes in Beneficial Ownership
4
Statement of Changes in Beneficial Ownership
4
Statement of Changes in Beneficial Ownership
144
Notice of Proposed Sale of Securities
8-K
SD
SEC Filing
10-Q
Quarterly Report
8-K
2.02,9.01
13G
Beneficial Ownership Report
DEFA14A
Additional Proxy Materials
DEF 14A
Definitive Proxy Statement
144
Notice of Proposed Sale of Securities
13G/A
Beneficial Ownership Report (Amended)
8-K
5.02,7.01,9.01
4
Statement of Changes in Beneficial Ownership
144
Notice of Proposed Sale of Securities
10-K
Annual Report
8-K
2.02,9.01
4
Statement of Changes in Beneficial Ownership

1-25 of 772

…
    GLOBUS MEDICAL INC (GMED) SEC Filings: 10-K, 10-Q, 8-K, Form 4 | Signal8